Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Endocrine Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02529579
What this trial is testing

Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
Changhai Hospital 187
Early research (Phase 1)UnknownNCT05240690
What this trial is testing

Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies

Who this might be right for
Stage IV Pancreatic CancerHepatocellular Carcinoma , Cholangiocarcinoma
Zhou Fuxiang 27
Not applicableStudy completedNCT05709197
What this trial is testing

The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy

Who this might be right for
Pancreatic DiseasePancreatic CancerDelayed Gastric Emptying
Radboud University Medical Center 256
Not applicableLooking for participantsNCT07636382
What this trial is testing

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain

Who this might be right for
Advanced CancerPancreatic Cancer
University Health Network, Toronto 5
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Testing effectiveness (Phase 2)Study completedNCT02905578
What this trial is testing

Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

Who this might be right for
Pancreatic NeoplasmsCancer of PancreasCancer of the Pancreas+4 more
University of Iowa 40
Not applicableUnknownNCT02817308
What this trial is testing

Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas

Who this might be right for
Carcinoma, Pancreatic Ductal
Rambam Health Care Campus 100
Not applicableStudy completedNCT02347618
What this trial is testing

Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma
University of Rochester 18
Not applicableStudy completedNCT03092310
What this trial is testing

Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index

Who this might be right for
Type 1 Diabetes Mellitus
Sansum Diabetes Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT01966393
What this trial is testing

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 23
Early research (Phase 1)Looking for participantsNCT06821048
What this trial is testing

Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerStomach CancerPancreatic Cancer+1 more
Weijia Fang, MD 18
Testing effectiveness (Phase 2)Ended earlyNCT03300843
What this trial is testing

Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer

Who this might be right for
MelanomaGastrointestinal CancerBreast Cancer+2 more
National Cancer Institute (NCI) 1
Not applicableLooking for participantsNCT06549725
What this trial is testing

Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening

Who this might be right for
Pancreas CancerPancreatic Ductal AdenocarcinomaHereditary Diseases+1 more
Lipidica, a.s. 419
Testing effectiveness (Phase 2)Study completedNCT00268840
What this trial is testing

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract Neoplasms
ARCAGY/ GINECO GROUP 45
Not applicableStudy completedNCT00937079
What this trial is testing

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

Who this might be right for
HyperinsulinismHypoglycemiaInsulinoma
University Hospital, Basel, Switzerland 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600233
What this trial is testing

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic Neuroendocrine TumorGastro-enteropancreatic Neuroendocrine Tumor+2 more
TaiRx, Inc. 34
Early research (Phase 1)Study completedNCT02050178
What this trial is testing

Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic CancerStage IV Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 26
Not applicableUnknownNCT05495685
What this trial is testing

IDentification and vAlidation Model of Liquid biopsY Based cfDNA Methylation and pRotEin biomArKers for Pancreatic Cancer (DAYBREAK Study)

Who this might be right for
Cancer
Changhai Hospital 450
Not applicableLooking for participantsNCT06705335
What this trial is testing

Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer
Institut Bergonié 50
Testing effectiveness (Phase 2)Study completedNCT02551991
What this trial is testing

Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Ipsen 56
Next Page